Ben Goodchild is a partner in the firm’s Mergers & Acquisitions Group. Ben advises public and private companies and their boards on their most significant transactions, corporate governance and activist defense matters, both domestic and cross-border. He works across a range of industries including healthcare and life sciences, consumer products, energy, technology and sports and entertainment.
Ben has twice been named a "Dealmaker of the Year" by The American Lawyer, in 2026 for guiding Metsera through the bidding war that led to its $10 billion sale to Pfizer, and in 2025 for representing Endeavor Energy Resources in its $26 billion merger with Diamondback Energy. He has also been recognized among Bloomberg Law's "They've Got Next: 40 Under 40" (2025), named one of Lawdragon's "500 Leading Global Entertainment, Sports & Media Lawyers" (2025) and cited by The Legal 500 for his work in sports transactions (2026).
Ben’s M&A experience includes a broad range of industries. Notable representations have included:
Healthcare & Life Sciences
- AbbVie in its $10.9 billion all-cash acquisition of Apogee Therapeutics and its acquisition of Landos Biopharma
- Albireo in its up to $1.3 billion sale to Ipsen
- Amedisys in its $3.3 billion combination with Optum
- Anika Therapeutics in acquisitions of Arthrosurface and Parcus Medical
- DeepIntent in its sale to Vitruvian Partners
- Eli Lilly in its up to $2.4 billion acquisition of Orna Therapeutics
- Galapagos in a research and development collaboration with Gilead in connection with Gilead’s $1.675 billion acquisition of Ouro Medicines
- The Glick Family Office in connection with its investment in Sonida Senior Living
- GSK in its:
- $2 billion acquisition of BELLUS Health
- $950 million acquisition of 35Pharma
- Acquisition of Elsie Biotechnologies
- Acquisition of CMG1A46 from Chimagen Biosciences
- Inhibrx in the $2.2 billion sale of INBRX-101 to Sanofi and the related spin-off of Inhibrx's non-INBRX-101 business
- Integra LifeSciences Holdings Corporation in its acquisition of ACell
- Masimo in its proxy contest against Politan Capital Management
- Merck KGaA in its approximately €5.8 billion acquisition of Versum
- Metsera in its $10 billion sale to Pfizer, following a series of competing bids for the company by Pfizer and Novo Nordisk
- UnitedHealth Group in its:
- $13.8 billion acquisition of Change Healthcare and related divestiture
- Acquisition of MCNA
- Acquisition of Healthplex
- Verve Therapeutics in its $1.3 billion acquisition by Eli Lilly
Consumer, Retail, Sports & Technology
- AB InBev in its agreement to produce Teavana Tea for Starbucks
- Broadcom in its sale and cross licensing of its Internet of Things business to Synaptics
- Chewy in its acquisition of SmartEquine from Covetrus
- CyrusOne in its strategic partnership with GDS Holdings
- DraftKings Inc. in its $1.56 billion acquisition of Golden Nugget Online Gaming
- Forge Nano in its $1.6 billion business combination with Archimedes Tech SPAC Partners II Co. to form a publicly-listed entity
- Gildan Activewear in its acquisition of American Apparel
- HelloFresh in its acquisition of Factor75
- Indeed in its $1.2 billion acquisition of Glassdoor
- Jim Ratcliffe in his acquisition of 25% of Manchester United Football Club
- Kering on its acquisition of Maui Jim
- Legacy Development Corporation on the long term lease of the London Olympic Stadium to West Ham Football Club
- SKIMS in its acquisition of SKKN by Kim
- Tiffany & Co. in its approximately €14.7 billion sale to LVMH Moët Hennessy Louis Vuitton
- Verifone in its acquisition of Zivelo
- World Wrestling Entertainment in its agreement with Endeavor Group Holdings to merge WWE with UFC to form a new publicly listed company, with an enterprise value of $21.4 billion
Private Capital
- Funds managed by affiliates of Apollo Global Management in its acquisition of Trace3 from American Securities
- Brown Brothers Harriman as a significant shareholder in connection with the going-public of Westrock Coffee at a $1.1 billion valuation
- A consortium consisting of General Atlantic and Stone Point Capital, in their $1.65 billion take-private acquisition of HireRight Holdings Corp.
- Rhône Capital in its acquisition of a controlling interest in GardaWorld at a $3.3 billion valuation
- Strategic Value Partners in its $1.125 billion acquisition of Revelyst, a segment of Vista Outdoor Inc.
- Thimble Point Acquisition Corporation in its business combination with Pear Therapeutics
Energy & Infrastructure
- Endeavor Energy Resources in its $26 billion merger with Diamondback Energy
- The Government of South Africa in respect of its RFPs for independent power production
- A group of investors in respect of a multibillion dollar claim under an investment treaty
- Kinross Gold in respect of the expansion of its Tasiast Gold mine
- Macquarie and Barclays in connection with the acquisition of various offshore transmission assets
- Noble Corporation in its $2.1 billion acquisition of Diamond Offshore Drilling
- Pilot Travel Centers in the acquisition by Berkshire Hathaway of 100% of the company, through the acquisition of the outstanding 20% minority position
- Zim Integrated Shipping Services on the restructuring of its bank, shipbuilder and capital markets financings, which was the largest restructuring in Israeli history
Banking & Finance
- Bank of N.T. Butterfield in its acquisition of two asset management businesses
- Blackstone Credit on its divestiture of mortgage servicing rights and related platform
- Enstar Group in its $5.1 billion take-private sale to Sixth Street and other institutional investors
- Envestnet in its $4.5 billion take-private sale to Bain Capital
- Goldman Sachs in its £3.5 billion sale of student housing assets in the UK
- GSO on its investment into Fidelity Guarantee and Life in connection with its going public transaction at a $1.84 billion valuation
